Wake Forest University Health Sciences: Lung Neoplasms trials

The registry lists 52 Lung Neoplasms studies with Wake Forest University Health Sciences as lead sponsor. 3 are open to participants now and 19 have results posted.

Early Phase 1 2Phase 1 6Phase 2 18Phase 3 3No phase 26(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Mobile Patient Health Technology Intervention for Improving Lung Cancer Screening Rates in Eligible High Risk PatientsRecruitingNCT07322367Not applicable
• A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT TrialNot yet recruitingNCT07282444Not applicable
• Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54RecruitingNCT04577599Not applicable
• Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer SurvivorsTerminatedNCT06654245Not applicableResults posted
• Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer PatientsTerminatedNCT04398199Phase 2Results posted
• Digital Outreach Intervention for Lung Cancer ScreeningCompletedNCT04083859Not applicableResults posted
• Exhaled Breath Analysis to Predict Risk of Symptomatic PneumonitisTerminatedNCT04040244Not applicableResults posted
• Metabolic and Microbial Profiling of Lung CancerTerminatedNCT03998189Not applicableResults posted
• High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung CancerTerminatedNCT03870529Early Phase 1Results posted
• Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung CancerCompletedNCT03867175Phase 3Results posted
• Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRTCompletedNCT03861091Phase 2Results posted
• Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung CancerTerminatedNCT03662074Phase 2Results posted
• Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLCActive, not recruitingNCT03141359Phase 2Results posted
• Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic MutationsTerminatedNCT02949843Phase 2Results posted
• Effect of Pembrolizumab With or Without Carboplatin and Paclitaxel on Immune Response in Patients With Recurrent or Stage IIIB-IV Non-small Cell Lung CancerCompletedNCT02581943Phase 2Results posted
• Pemetrexed Disodium in Treating Patients With Stage IV Non-small Cell Lung Cancer and ECOG Performance Status 3CompletedNCT02426658Phase 2Results posted
• LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL CancerCompletedNCT02328105Phase 2Results posted
• Reducing Lung Cancer-Related Anxiety (RELAX)TerminatedNCT02063828Not applicableResults posted
• Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT01557959Phase 2Results posted
• Memantine Hydrochloride in Helping Cancer Survivors Stop SmokingCompletedNCT01535040Phase 2Results posted
• Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer PatientsCompletedNCT01434342Early Phase 1Results posted
• Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT00499447Not applicableResults posted
• A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care ResourcesActive, not recruitingNCT06383988Not applicable
• COPD Care Pathway Among Patients With CancerCompletedNCT05984680
• Testing the Feasibility of a Simplified Workflow for Lung CancerCompletedNCT04844736Not applicable
• Pilot Study of SGRT Alone vs. SGRT With Fiducials for Breath Hold SBRT tx of the LungActive, not recruitingNCT04060927Not applicable
• Paclitaxel Therapeutic Drug Monitoring in Cancer PatientsSuspendedNCT03987555
• Connect Oncology Needs Evaluation ToolCompletedNCT03919864Not applicable
• Changes in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung CancerCompletedNCT03746262
• Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line ImmunotherapyCompletedNCT03741868
• CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung CancerWithdrawnNCT03370159Phase 1/2
• Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening InterventionCompletedNCT02962115Not applicable
• Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung CancerWithdrawnNCT02835066
• Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by SurgeryTerminatedNCT02566421Not applicable
• Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerWithdrawnNCT02014545Phase 2
• Bioelectrical Impedance Phase Angle in Predicting Treatment Outcome in Patients With Extensive Stage Small Cell Lung Cancer Receiving First-Line ChemotherapyTerminatedNCT02011087Not applicable
• CPI-613 in Treating Patients With Relapsed or Refractory Small Cell Lung CancerCompletedNCT01931787Phase 1
• Molecular and Diagnostic Classification of Non-Small Cell Lung Cancer From Fine Needle AspiratesCompletedNCT01630122
• Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung CancerCompletedNCT01457469Phase 1
• Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the BodyWithdrawnNCT01325753Not applicable
• Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)CompletedNCT01126346Not applicable
• Thermal Ablation Combined With External Beam Radiation Therapy for Patients With Inoperable Non-Small Cell Lung Cancer > 3.5 cm in SizeTerminatedNCT01028612Not applicable
• Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung CancerCompletedNCT01026467
• Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerWithdrawnNCT00471835Phase 1/2
• Zinc Supplements in Lowering Cadmium Levels in SmokersCompletedNCT00376987Phase 2
• Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00310154Phase 1
• Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00278460Phase 2
• Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung CancerCompletedNCT00031785Phase 3
• Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung CancerCompletedNCT00028938Phase 3
• Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00025285Phase 2
• Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00025272Phase 2
• Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT00003202Phase 1/2